Our Story

It began with a vision — to redefine cancer treatment by merging precision diagnostics with drug development. Recognizing the urgent need for therapies tailored to individual patients, Welmedis set out to bridge the gap between newly identified cancer targets and treatment, ensuring that every breakthrough in research translated into real-world impact.

This mission took shape through the fusion of cutting-edge technology and scientific expertise, which became the foundation for accelerating the development of next-generation therapies. But innovation alone wasn’t enough. The key was integration — bringing together molecular insights and drug discovery to create highly targeted treatments for specific cancer types. To achieve this, we built a powerhouse of collaboration. Our specialized laboratories in Germany, Switzerland, and Greece, together with expert CROs, create a dynamic network dedicated to pushing the boundaries of oncology research.